相关实验视频

Updated: Sep 9, 2025

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

帕金森病的异构骨髓衍生细胞干细胞:随机试验

Mya C Schiess¹, Jessika Suescun¹, Juan D Martinez-Lemus¹

¹Movement Disorders Division, Department of Neurology, McGovern Medical School at UTHealth Houston, Houston, Texas, USA.

Movement disorders : official journal of the Movement Disorder Society

|September 2, 2025

概括

在帕金森病患者中,三次注射全基因人间干细胞 (allo-hMSC) 改善了运动功能. 两种输液的效果低于安慰剂,突显了对帕金森病干细胞治疗的进一步研究的需要.

科学领域:

神经科学
复原医学
临床试验

背景情况:

神经炎症是帕金森病进展和运动缺陷的关键因素.
人类半细胞干细胞 (allo-hMSCs) 在缓解神经炎症和改善PD运动症状方面具有潜力.

研究的目的:

评估多次静脉注射 (10 × 10 ^ 6 / kg) 的阿洛-hMSCs在增强帕金森病患者的运动功能的有效性.

主要方法:

一个2期,随机,安慰剂对照试验,涉及45个轻度至中度PwP.
参与者在18周的间隔内接受了三个alo- hMSC输液,一个混合方案 (一个安慰剂,两个alo- hMSC) 或三个安慰剂.
通过贝叶斯方法分析,第62周的MDS- UPDRS- III得分提高了≥5分.

主要成果:

与安慰剂相比,三次输液组的参与者中MDS- UPDRS- III改善的比例更高 (93. 7% PP).
两次输液组的改善明显低于安慰剂组 (≥99. 9% PP的差异).
所有治疗组都观察到MDS- UPDRS- III得分有所改善,并出现轻度和短暂的不良反应.

结论:

在轻度至中度帕金森病患者中,三次alo- hMSC输液有效改善了运动功能.
两次输液的效果低于安慰剂,这表明剂量或可变性问题.
未来的研究应包括功能性强度测试,以调查影响alo- hMSC临床疗效的批量变异性.

关键词:

帕金森病基干细胞静脉注射静脉注射介质干细胞随机对照试验

更多相关视频

Isolating Nasal Olfactory Stem Cells from Rodents or Humans

Isolating Nasal Olfactory Stem Cells from Rodents or Humans

Published on: August 22, 2011

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...